rawfin.tv
Oramed CSO Disposes of Shares for RSU Tax Obligations
MarketsstocksAI Generated

Oramed CSO Disposes of Shares for RSU Tax Obligations

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Oramed Pharmaceuticals Inc.'s Chief Scientific Officer, Miriam Kidron, reported a disposition of 435,084 common shares. The transaction was explicitly stated as a tax-related sale to cover RSU obligations.

Insider TradingPharmaceuticalsBiotech StocksShare SaleTax Implications

Related Articles

Ambarella Gains as Nvidia Emerges as Potential Third Bidder

Ambarella Gains as Nvidia Emerges as Potential Third Bidder

stocks
SpaceX and Tesla Boards Review Potential $3.5 Trillion Merger

SpaceX and Tesla Boards Review Potential $3.5 Trillion Merger

stocks
Elon Musk Explores Merger Between SpaceX and Tesla

Elon Musk Explores Merger Between SpaceX and Tesla

stocks
Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks